SV

Co-founder · CEO / CTO Sai Akhilesh Veldi

Data Engineer at A2ZSync, where he builds ETL pipelines and ships production AI/ML systems. Previously interned at Sage Therapeutics on the postpartum depression (PPD) program that became Zurzuvae (FDA-approved 2023), where he built NLP sentiment-analysis pipelines on patient-outcome data and worked hands-on with HIPAA- and PII-compliant data systems, drug commercialization pipelines, and FDA-regulated clinical workflows. At Shunaka, he designs the AI and software backbone that scales precision medicine from one patient at a time to population scale.

AB

Co-founder · Chief Scientist Abhilash Boppana

Research Assistant at UT Southwestern Medical Center, where his work on preclinical nuclear imaging in oncology has been published in the Journal of Nuclear Medicine. The work uses animal models implanted with human cancer cells to track tumor biology in vivo. He moves comfortably between wet-lab benchwork and dry-lab computational imaging analysis, with day-to-day work that spans IACUC protocols, USDA-regulated animal studies, GLP-compliant preclinical workflows, and AAALAC-accredited research facilities. At Shunaka, he leads the scientific direction. Every model the platform produces stands up to real biology and regulatory scrutiny.